COVID-19 pandemic The Brazilian Health Regulatory Agency (Anvisa) grants emergency use authorization requests for the vaccines developed by Sinovac and Oxford-AstraZeneca. Anvisa autoriza por unanimidade uso emergencial das vacinas Coronovac e de Oxford contra a Covid-19 © G1 Sources: G1
:strip_icc()/s01.video.glbimg.com/x720/606348.jpg "Anvisa autoriza por unanimidade uso emergencial das vacinas Coronovac e de Oxford contra a Covid-19 © G1")